Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
By supplying an adequate amount of calcium and vitamin D with the addition of weekly
bisphosphonate, the investigators will be able to increase bone mass and decrease the
incidence of fragility fractures in these children with muscular dystrophy.
The investigators think this treatment will also decrease the intensity of pain frequently
present in these patients and slow the progression of scoliosis.